EP
IONS icon

Eversept Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Eversept Partners’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.5M Buy
632,100
+93,882
+17% +$7.41M 2.5% 12
2025
Q4 		$42.6M Sell
538,218
-443
-0.1% -$33.4K 2.15% 13
2025
Q3 		$35.2M Sell
538,661
-50,239
-9% -$2.45M 2.43% 13
2025
Q2 		$23.3M Buy
588,900
+71,879
+14% +$2.35M 2.14% 11
2025
Q1 		$15.6M Buy
517,021
+302,069
+141% +$9.89M 1.58% 24
2024
Q4 		$7.51M Sell
214,952
-256,403
-54% -$9.58M 0.67% 31
2024
Q3 		$18.9M Buy
471,355
+14,474
+3% +$673K 1.29% 21
2024
Q2 		$21.8M Buy
456,881
+80,443
+21% +$3.3M 1.49% 17
2024
Q1 		$16.3M Buy
376,438
+51,784
+16% +$2.47M 1.09% 19
2023
Q4 		$16.4M Buy
324,654
+72,208
+29% +$3.46M 1.44% 18
2023
Q3 		$11.5M Buy
252,446
+10,874
+5% +$449K 0.97% 22
2023
Q2 		$9.91M Sell
241,572
-61,797
-20% -$2.37M 0.83% 27
2023
Q1 		$10.8M Buy
303,369
+62,394
+26% +$2.34M 0.76% 29
2022
Q4 		$9.1M Buy
240,975
+39,142
+19% +$1.65M 0.8% 27
2022
Q3 		$8.93M Buy
201,833
+115,522
+134% +$4.87M 0.77% 30
2022
Q2 		$3.2M Sell
86,311
-72,495
-46% -$2.73M 0.23% 54
2022
Q1 		$5.88M Sell
158,806
-225,983
-59% -$7.4M 0.45% 46
2021
Q4 		$11.7M Sell
384,789
-65,712
-15% -$2.07M 0.75% 38
2021
Q3 		$15.1M Buy
450,501
+8,501
+2% +$320K 1.05% 29
2021
Q2 		$17.6M Buy
+442,000
New +$17.3M 1.18% 26

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eversept Partners's IONS Position: Q1 2026 in Review

Eversept Partners increased its Ionis Pharmaceuticals (IONS) stake by 17% in Q1 2026, buying an estimated $7.41M and bringing the position to 632,100 shares worth $47.5M. The position accounts for 2.5% of the portfolio, ranked #12.

Eversept Partners first reported a position in IONS in Q2 2021 and has held it in 20 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Eversept Partners held 632,100 shares of Ionis Pharmaceuticals worth $47.5M as of Q1 2026.
  • Eversept Partners bought 93,882 Ionis Pharmaceuticals shares in Q1 2026, an estimated $7.41M.
  • Ionis Pharmaceuticals made up 2.5% of Eversept Partners's portfolio in Q1 2026, its #12 holding.
  • Eversept Partners first reported a position in Ionis Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.